WithdrawnNot Applicable

FaibaLite - Reduce Weight, One Bite at a Time

Stopped: Competing study and lack of resource

0Started 2026-01-01

Plain-language summary

This study aims to evaluate the suitability of a fiber-enriched chewing gum as a practical and accessible approach to support healthy body weight management.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Written Informed Consent * Healthy adults aged 18 to 65 years (inclusive), as determined by the investigator * BMI of 23 to 40 kg/m2 (inclusive) * Living in Switzerland * Ability and willingness to follow the study protocol (e.g., cognitive capacity for compliance, gum chewing) * Access and willingness to use an electronic device (e.g., mobile phone, computer or tablet) * Access to a scale to self-report weight Exclusion Criteria: * Current weight loss therapy with Glucagon-like Peptide 1 (GLP-1) agonists or other non-prescription products (at investigator's discretion) * Treatment with a GLP-1 agonist within the past 2 months * Initiation/Discontinuation of nicotine product use (\>1 nicotine product per day, e.g., (e-)cigarette, gum) within the last 2 months (at investigator's discretion) * Significant change in medication within the last 2 months (at investigator's discretion) * Unable to chew gum 3 times daily (e.g. due to dental issues, at investigator's discretion)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Composite primary endpoint: Feasibility of conducting the study based on participant adherence rate, user acceptance score, and dropout rate

Timeframe: Up to 3 months (end of chewing phase)

Trial details

NCT IDNCT07045766

SponsorUniversity of Bern

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-28

View on ClinicalTrials.gov More Nutritional and Metabolic Diseases trials

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.